Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | PDE4A | P27815 | 3/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2506935 | 0.94 | HCRTR2 (0.36) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 | |
| SCHEMBL11894647 | 0.92 | HCRTR2 (0.36) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 | |
| SCHEMBL11894645 | 0.92 | HCRTR2 (0.36) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 | |
| SCHEMBL425191 | 0.89 | SCN9A (0.40) | ALDH1A1CYP1A2MAPTCYP2C9CYP2C19 | |
| Ethylene SCHEMBL5076561 | 0.89 | HCRTR2 (0.33) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 | |
| SCHEMBL14922531 | 0.87 | KDM1A (0.41) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C19 | |
| SCHEMBL2506385 | 0.86 | PTPN1 (0.37) | ALDH1A1MAPTMEN1KMT2ALMNA | |
| SCHEMBL7787604 | 0.85 | KDM1A (0.35) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 | |
| SCHEMBL28677635 | 0.84 | PDE4A (0.35) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 | |
| SCHEMBL30209607 | 0.84 | PDE4A (0.35) | HCRTR2ALDH1A1CYP1A2MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107573212-B | Synthesis method of trans-4-alkyl cyclohexyl benzene structure liquid crystal intermediate and monomer | 宁夏中星显示材料有限公司 | 2020-08-04 | — | — | CN | disclosed |
| EP-2479162-B1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| EP-2479162-B1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2305627-B1 | TETRACYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2014-09-17 | — | — | EP | disclosed |
| EP-2266941-B1 | TRICYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-8580147-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-8580146-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-8580146-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-8394294-B2 | Four-ring liquid crystal compound having lateral fluorine, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| WO-2009150966-A1 | TETRACYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | チッソ株式会社 (JP) | 2009-12-17 | — | — | WO | disclosed |
| WO-2009125668-A1 | TRICYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | チッソ株式会社 (JP) | 2009-10-15 | — | — | WO | disclosed |
| EP-1362839-B1 | Liquid crystal composition having a positive delta-epsilon and liquid crystal display device | CHISSO CORP (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7081279-B2 | Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2006-07-25 | — | — | US | disclosed |
| US-20040065866-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| US-6692657-B1 | ALKENYL COMPOUND WITH 2,3-DIFLUOROPHENYL GROUP | CHISSO CORPORATION (JP) | 2004-02-17 | — | — | US | disclosed |
| EP-1362839-A2 | Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device | CHISSO CORPORATION (JP) | 2003-11-19 | — | — | EP | disclosed |
| EP-0969071-B1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device | CHISSO CORP (JP) | 2003-11-05 | — | — | EP | disclosed |
| US-6475595-B1 | ELECTROOPTICS | MERCK GMBH (DE) | 2002-11-05 | — | — | US | disclosed |
| EP-0969071-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2000-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040065866-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition, and liquid crystal display device | CTNND1, CCT4, DLK1 | HCRTR2 4280/4885ALDH1A1 1284/4885CYP1A2 4093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.